154 related articles for article (PubMed ID: 9195494)
21. Supratentorial gliomas: a comparative study by grade and histologic type.
Shaw EG; Scheithauer BW; O'Fallon JR
J Neurooncol; 1997 Feb; 31(3):273-8. PubMed ID: 9049856
[TBL] [Abstract][Full Text] [Related]
22. Gemistocytic astrocytomas: a reappraisal.
Krouwer HG; Davis RL; Silver P; Prados M
J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
[TBL] [Abstract][Full Text] [Related]
23. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
Deckert M; Reifenberger G; Wechsler W
J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
[TBL] [Abstract][Full Text] [Related]
24. Proliferating cell nuclear antigen (PCNA) in low-grade astrocytomas: its prognostic significance.
Vigliani MC; Chiò A; Pezzulo T; Soffietti R; Giordana MT; Schiffer D
Tumori; 1994 Aug; 80(4):295-300. PubMed ID: 7974802
[TBL] [Abstract][Full Text] [Related]
25. Detection of proliferating cell nuclear antigen in gliomas and adjacent resection margins.
Kim DK; Hoyt J; Bacchi C; Keles GE; Mass M; Mayberg MR; Berger MS
Neurosurgery; 1993 Oct; 33(4):619-25; discussion 625-6. PubMed ID: 7901794
[TBL] [Abstract][Full Text] [Related]
26. [Results of the Sainte-Anne - Lyons series of 318 oligodendroglioma in adults].
Nataf F; Koziak M; Ricci AC; Varlet P; Devaux B; Beuvon F; Roujeau T; Page P; Cioloca C; Turak B; Schlienger M; Touboul E; Haie-Meder C; Vannetzel JM; Dhermain F; Honnorat J; Jouvet A; De Saint-Pierre G; Daumas-Duport C; Bret P; Roux FX
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):329-51. PubMed ID: 16292177
[TBL] [Abstract][Full Text] [Related]
27. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
28. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.
Soffietti R; Rudà R; Bradac GB; Schiffer D
Neurosurgery; 1998 Nov; 43(5):1066-73. PubMed ID: 9802850
[TBL] [Abstract][Full Text] [Related]
29. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
30. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
[TBL] [Abstract][Full Text] [Related]
31. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
[TBL] [Abstract][Full Text] [Related]
33. CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas.
Miettinen H; Kononen J; Sallinen P; Alho H; Helen P; Helin H; Kalimo H; Paljärvi L; Isola J; Haapasalo H
J Neurooncol; 1999 Feb; 41(3):205-11. PubMed ID: 10359140
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
Chaichana KL; McGirt MJ; Niranjan A; Olivi A; Burger PC; Quinones-Hinojosa A
Neurol Res; 2009 Nov; 31(9):931-9. PubMed ID: 19215664
[TBL] [Abstract][Full Text] [Related]
35. Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults.
Alvarez de Eulate-Beramendi S; Rigau V; Taillandier L; Duffau H
J Neurosurg; 2014 Apr; 120(4):833-9. PubMed ID: 24286144
[TBL] [Abstract][Full Text] [Related]
36. A 31-year-old woman with a transformed low-grade glioma.
Warnke PC
JAMA; 2010 Mar; 303(10):967-76. PubMed ID: 20159860
[TBL] [Abstract][Full Text] [Related]
37. The Ki-67 labeling index as a prognostic factor in Grade II oligoastrocytomas.
Shaffrey ME; Farace E; Schiff D; Larner JM; Mut M; Lopes MB
J Neurosurg; 2005 Jun; 102(6):1033-9. PubMed ID: 16028762
[TBL] [Abstract][Full Text] [Related]
38. Interstitial radiosurgery of low-grade gliomas.
Kreth FW; Faist M; Warnke PC; Rossner R; Volk B; Ostertag CB
J Neurosurg; 1995 Mar; 82(3):418-29. PubMed ID: 7861220
[TBL] [Abstract][Full Text] [Related]
39. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
[TBL] [Abstract][Full Text] [Related]
40. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
